Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
2nd EACR conference on Radiation Break-through: from DNA damage responses to precision cancer therapy

2nd EACR conference on Radiation Break-through: from DNA damage responses to precision cancer therapy

12 - 14 Mar

Wolfson College, Oxford, United Kingdom

Aims

March 2018

Mon Tue Wed Thu Fri Sat Sun
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31  

It is designed to be of interest to cancer scientists and medical oncologists with expertise in basic, translational and clinical research.

Its objective is to cover recent and exciting developments in the field that are crucial to our understanding of the multifaceted role of the DNA damage response and associated tumour cell specific alterations in cancer initiation, progression and precision cancer therapy.

It is an exciting and rapidly evolving research field that will expedite the development and implementation of biomarkers for patient stratification and of novel treatment concepts in precision cancer medicine.

Topics to be covered

  • Mechanistic insights into the cellular responses to DNA damage and genomic stability
  • Therapeutic exploitation of defective DNA damage response and repair
  • New treatment approaches combining radiotherapy with targeted drugs or immunotherapy
  • Radiobiology biomarkers for precision radiotherapy

More information is available from the Conference Web Site

Add to Outlook / iCal

There is currently no content available for 2nd EACR conference on Radiation Break-through: from DNA damage responses to precision cancer therapy. Please visit this page again soon.



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation